PL424583A1 - New peptidomimetic, method for obtaining it and fluorescent application - Google Patents

New peptidomimetic, method for obtaining it and fluorescent application

Info

Publication number
PL424583A1
PL424583A1 PL424583A PL42458318A PL424583A1 PL 424583 A1 PL424583 A1 PL 424583A1 PL 424583 A PL424583 A PL 424583A PL 42458318 A PL42458318 A PL 42458318A PL 424583 A1 PL424583 A1 PL 424583A1
Authority
PL
Poland
Prior art keywords
obtaining
application
fluorescent
new
fluorescent application
Prior art date
Application number
PL424583A
Other languages
Polish (pl)
Other versions
PL238871B1 (en
Inventor
Magdalena WYSOCKA
Adam LESNER
Original Assignee
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Gdański filed Critical Uniwersytet Gdański
Priority to PL424583A priority Critical patent/PL238871B1/en
Publication of PL424583A1 publication Critical patent/PL424583A1/en
Publication of PL238871B1 publication Critical patent/PL238871B1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem zgłoszenia jest nowy związek Fl-O2Oc-Dap((GO2)6-O2Oc-NH2, sposób jego otrzymywania oraz zastosowanie fluorescencyjne nowego związku do wykrywania substancji w jądrach komórkowych.The subject of the application is a new compound Fl-O2Oc-Dap ((GO2) 6-O2Oc-NH2, the method of its preparation and the fluorescent application of the new compound to detect substances in cell nuclei.

PL424583A 2018-02-13 2018-02-13 New peptidomimetic, method for obtaining it and fluorescent application PL238871B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL424583A PL238871B1 (en) 2018-02-13 2018-02-13 New peptidomimetic, method for obtaining it and fluorescent application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL424583A PL238871B1 (en) 2018-02-13 2018-02-13 New peptidomimetic, method for obtaining it and fluorescent application

Publications (2)

Publication Number Publication Date
PL424583A1 true PL424583A1 (en) 2019-08-26
PL238871B1 PL238871B1 (en) 2021-10-18

Family

ID=67683621

Family Applications (1)

Application Number Title Priority Date Filing Date
PL424583A PL238871B1 (en) 2018-02-13 2018-02-13 New peptidomimetic, method for obtaining it and fluorescent application

Country Status (1)

Country Link
PL (1) PL238871B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003166A1 (en) * 2003-07-08 2005-01-13 Amersham Health As Fluorescein-labelled peptides
WO2014053880A1 (en) * 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2017150997A1 (en) * 2016-03-04 2017-09-08 Instytut Biotechnologii I Medycyny Molekularnej Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003166A1 (en) * 2003-07-08 2005-01-13 Amersham Health As Fluorescein-labelled peptides
WO2014053880A1 (en) * 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2017150997A1 (en) * 2016-03-04 2017-09-08 Instytut Biotechnologii I Medycyny Molekularnej Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAGDALENA WYSOCKA, PEGYLATED SUBSTRATES OF NSP4 PROTEASE: A TOOL TO STUDY PROTEASE SPECIFICITY *

Also Published As

Publication number Publication date
PL238871B1 (en) 2021-10-18

Similar Documents

Publication Publication Date Title
CL2020001048A1 (en) Monoclonal antibodies against bcma. (divisional request 201800281)
GB2569252A (en) Methods of combining the detection of biomolecules into a single assay using fluorescent in situ sequencing
CL2020000281A1 (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies, and methods of using anti-cd39 antibodies
CO6680668A2 (en) Biomarker assays to detect or measure inhibition of tor kinase activity
CL2017001940A1 (en) Soil quality measuring device
EP4368992A3 (en) Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue
WO2018208091A3 (en) Biomarker for monitoring or diagnosing onset of liver cancer in high-risk group for liver cancer and use thereof
EA201890869A2 (en) APPLICATION OF BLUTON THYROSIN KINASE INHIBITORS (BTK)
BR112015022934A2 (en) neuroactive steroids, compositions, and use thereof
CL2010001483A1 (en) Compounds derived from 5-phenyl-1h-pyridin-2-one and 6-phenyl-2h-pyridazin-3-one, tyrosine kinase inhibitors (btk); Pharmaceutical composition comprising said compounds and their use for the treatment of an inflammatory and / or autoimmune pathological state.
AR102517A1 (en) TESTS TO DETECT IMMUNE SUBGROUPS OF T-CELLS AND THEIR METHODS OF USE
AR107529A1 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE STRATIFICATION OF CANCER PATIENTS AND THEIR TREATMENT
UY35460A (en) FORMULATIONS OF ANTIBODIES ANTI-RECEIVER OF PROLACTIN
PE20160549A1 (en) STABLE LIQUID FORMULATION OF ETHELCALCETIDA (AMG 416)
EA201500080A1 (en) METHOD IN VITRO DIAGNOSIS AND MONITORING OF CANCER
ATE548050T1 (en) DIAGNOSTIC PROCEDURE
EA202190633A1 (en) DOSAGE FORMS FOR USE IN PEDIATRICS, METHODS OF OBTAINING AND APPLICATION
MY193895A (en) Combination test for colorectal cancer
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody
EP3557259A3 (en) Methods and arrays for use in the same
MX363679B (en) Method of diagnosing cancer.
CL2018001138A1 (en) An ex vivo method to test the cellular response of primary cell populations to a drug or drug combination
PL424583A1 (en) New peptidomimetic, method for obtaining it and fluorescent application
RU2013135809A (en) METHOD FOR PREDICTING THE CHEMOTHERAPY EFFICIENCY IN PATIENTS WITH MALIGNANT NORMOUS FORMATIONS OF EPITELIAL TISSUES
SG10201901836PA (en) Test strip assembly